Nomura Holdings
ACHN

Nomura Holdings’s Achillion Pharmaceuticals ACHN Stock Holding History

Nomura Holdings’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,232
Closed -$121K – 2171
2015
Q4 		$121K Buy
+11,232
New +$102K ﹤0.01% 1680
2015
Q2 		– Sell
-14,340
Closed -$135K – 2150
2015
Q1 		$135K Buy
14,340
+4,115
+40% +$51.4K ﹤0.01% 1566
2014
Q4 		$121K Sell
10,225
-11,275
-52% -$138K ﹤0.01% 2128
2014
Q3 		$204K Buy
21,500
+9,849
+85% +$91.4K ﹤0.01% 2408
2014
Q2 		$84K Sell
11,651
-34,280
-75% -$137K ﹤0.01% 2557
2014
Q1 		$151K Sell
45,931
-79,200
-63% -$277K ﹤0.01% 2418
2013
Q4 		$409K Sell
125,131
-444,637
-78% -$1.29M ﹤0.01% 1379
2013
Q3 		$1.9M Buy
569,768
+495,032
+662% +$3.39M 0.01% 853
2013
Q2 		$612K Buy
+74,736
New +$571K 0.01% 1204

Nomura Holdings's ACHN Position: Q1 2016 in Review

Nomura Holdings sold out of Achillion Pharmaceuticals (ACHN) in Q1 2016, closing a stake of 11,232 shares — an estimated $121K sold.

Nomura Holdings first reported a position in ACHN in Q2 2013 and held it in 9 quarters. The position peaked at $1.9M in Q3 2013. 153 funds tracked by Wall St. Rank hold ACHN as of Q1 2016.

  • Nomura Holdings reported no remaining Achillion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Nomura Holdings sold 11,232 Achillion Pharmaceuticals shares in Q1 2016, an estimated $121K.
  • Nomura Holdings first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 9 quarters.
  • Nomura Holdings's Achillion Pharmaceuticals position peaked at $1.9M in Q3 2013.
  • 153 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2016.

Based on Nomura Holdings's 13F filing for Q1 2016, filed 16 May 2016.